Viewing Study NCT02819856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-02-25 @ 11:02 PM
Study NCT ID: NCT02819856
Status: COMPLETED
Last Update Posted: 2024-08-02
First Post: 2016-06-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
Sponsor: Sound Pharmaceuticals, Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ototoxicity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ebselen View
None Tinnitus View
None Hearing Loss View
None Vertigo View
None Cystic Fibrosis View
None Pulmonary Exacerbation View
None Tobramycin View
None Safety View
None Pharmacokinetics View
None Pharmacodynamics View
None Aminoglycoside View
None SPI-1005 View
None Efficacy View
None Pharmacogenomics View
None Ototoxicity View